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Abstract
Background: In the Arab world, intervention and policy response to non-communicable diseases (NCD) has been
weak despite extensive epidemiological evidence highlighting the alarmingly increased prevalence of chronic
diseases. Generating genetic information is one key component to promote efficient disease management
strategies. This study undertook a scoping review to generate the profile of the undertaken research on genetics of
NCD publications in selected Arab countries. An analysis of the research produced examined the extent, range,
nature, topic and methods of published research. The study aimed at identifying the gaps in genetic NCD research
to inform policy action for NCD prevention and control.
Methods: The scoping review was conducted based on the five-stage methodological framework and included
countries in Arab region selected to represent various economies and epidemiological transitions.
Results: The search identified 555 articles that focus on genetics-NCD research in the selected Arab countries over the
duration of this study (January 2000 to December 2013). The most commonly conducted research was descriptive and
clinically focused, rather than etiologically focused. Country-specific carrier and risk screening studies were not among
the top research designs. The genetic component of certain highly heritable diseases, as well as diabetes, obesity,
hypertension, chronic lung dysfunction and metabolic syndrome were all under investigated.
Conclusions: This scoping review identified gaps for further research in the context of bioinformatics and genome-
wide association studies. Genetic research in the Arab region has to be redirected towards NCDs with the highest
morbidity, heritability and health burden within each country. A focused research plan to include community genetics
is required for its proper integration in the Arab community.
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Background
Non-communicable diseases (NCD), including cardio-
vascular diseases (CVD), diabetes and several cancers,
remain among the leading causes of adult morbidity and
mortality worldwide, with a growing economic burden
[1]. The alarming rise in NCD burden in both developed
and underdeveloped countries has prompted the World
Health Assembly 2008 to provide a global strategy on
NCD prevention and control [2]. The strategy aimed to
generate informed knowledge and transform it into cost-
effective actions directly capable of elevating the burden.
The approach provided a general review on the current
status of NCD knowledge and research gaps, with genet-
ics being an important domain, among other factors.
Generating genetic information is a key component in
promoting efficient disease management strategies. In
fact, investigations targeting chronic disease genetic
variants provide better opportunities for screening, diag-
nosis, and early effective intervention.
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On the knowledge production front, advances in the
mapping of the human genome (through the Human
Genome Project) have greatly contributed to a better
understanding of the genetics basis of NCDs. The pres-
ence of one or more gene mutations and/or a combin-
ation of alleles connotes a genetic predisposition or
susceptibility to a disease. Through the lens of genome-
wide association studies (GWAS), around 160 loci have
been identified and associated with CVD, adding sub-
stantial contribution to our understanding of the disease
[3]. Research is still ongoing in order to understand the
genetic basis of chronic diseases and projects, such as
the Encyclopedia of DNA Elements (ENCODE), are cur-
rently annotating the noncoding region of the genome
to provide new insight in gene regulation [4]. On the
clinical front, integration of genetic information has pro-
vided ground-breaking application at different stages of
disease management, from risk assessment and screen-
ing to diagnosis prognosis and treatment. In the case of
breast and ovarian cancer, for example, genotyping is
used to determine susceptibility to the disease, predict
likelihood of recurrence and inform treatment [5].
Furthermore, revelation of novel biological pathways in
type 2 diabetes predictions offers hope in providing early
intervention, prevention and progression management.
The common variant in the gene encoding the transcrip-
tion factor 7-like gene (TCF7L2) confers greater diabetes
risk (odds ratio, 1.81) to carriers compared to non-variant
carriers [6, 7]. Genome-based tools have been also applied
in pharmaceutical clinical practice for proper disease man-
agement. Pharmacogenomics has provided an opportunity
for optimized drug dosing to avoid toxicity and improve
efficacy, such as the case of CYP2C9/VKORC1 and war-
farin [8]. In the context of behavioural modification, it has
been documented that genetic knowledge plays a role in
increased compliance to interventions. Dietary recommen-
dations based on genetics were reported to be more com-
prehensible and resulted in longer-term weight reduction
compared to normal dietary recommendations [9, 10].
Investigating genetics of NCD while taking into con-
sideration the specific populations and ethnic variations
offer a specifically efficient disease management. Differ-
ent ethnic groups have reported differences in gene
polymorphism frequencies and have identified new
genetic variations. Frequency of leiomyoma-related
gene polymorphism differs significantly based on ethnic
background; for example, African American women
had a higher frequency of the PP genotype (35 %)
compared to Caucasian (13 %) and Hispanic (16 %)
women [11]. Moreover, many novel genetic variations
have been noted in different communities. A molecular
study in Lebanese adults has identified a differential
duplication of an intron region in a NFATC1 gene
associated with congenital heart disease [12].
In the Arab world, policy response to the rise in NCD
has been relatively weak despite the extensive epidemio-
logical evidence on its prevalence [13]. To be able to adopt
and accommodate global and regional strategies in re-
sponse to the NCD burden, it is important to identify and
analyse the available knowledge, perform regional cross-
country comparisons and align national needs with an
efficient research agenda. With regards to genetic research
in the Arab world, several efforts are worth noting to
increase genetic research in the region. In Saudi Arabia,
the Saudi Human Genome Program was set up as a re-
search centre to identify the genetic basis of inherited
diseases in the Saudi population [14]. In the United Arab
Emirates, a biannual conference takes place (Pan Arab
Human Genetics Conference) in order to provide a plat-
form for regional and international genetics researchers to
meet and discuss genetics-related topics [15]. Data
from the ‘Catalogue for Transmission Genetics in Arabs’
database, curated by the Center for Arab Genomic Stud-
ies, identified more than 60 recessive genes in the region
[16, 17]. Despite those efforts and progress, several papers
noted the need for additional comprehensive genetic
research targeted at understanding the molecular etiology
of genetic related diseases in the Arab world [18].
The study was undertaken to map publications on
genetics of NCD from 2000–2013 in selected representa-
tive Arab countries. The analysis will generate a profile
of the undertaken research both at the level of quantity
and quality, highlight disparities between research out-
put and country-specific needs and disease burden, serve
as a foundation of systemic review, provide a database of
the articles covering this research area and, finally, when
disseminated, help redirect research agendas to generate
knowledge that would have high impact on disease bur-
den alleviation.
Methods
Identification of the relevant studies
The current study stems from a broad scoping review
analysis of NCD publications in selected Arab countries
following Arksey’s and O’Malley’s five-stages methodo-
logical framework: identification of the research purpose,
identification of relevant studies, study selection, data
charting, and results summary [19]. The countries were
selected to represent varied economies and epidemio-
logic transitions and included Bahrain, Iraq, Kuwait,
Lebanon, Morocco, Palestine and Sudan. These coun-
tries are classified based on World Bank Gross Domestic
Product data into low middle-income countries (Sudan,
Palestine and Morocco), upper middle-income countries
(Iraq and Lebanon), and high-income countries (Bahrain
and Kuwait) [20].
An extensive systematic library search was completed
based on probes proposed by a specialized team. The
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literature search was conducted electronically using
PubMed, searching articles from January 1, 2000, until
December 31, 2013. The search strategy included,
among others, a genetic component using the following
terms: genetic polymorphism OR gene polymorphism
OR genetic pedigree OR SNP OR GWAS OR genotype
OR gene variants OR mutation OR risk allele OR genetic
risk factors OR genetic analysis OR candidate gene OR
gene. NCD outcomes focused on the four prominent
conditions: CVDs, cancers, chronic obstructive pulmon-
ary disease and diabetes. NCD-related terms used for
the search strategy included coronary artery disease OR
myocardial infarction OR angina pectoris OR peripheral
vascular disease OR peripheral arterial disease OR
atherosclerosis OR thrombosis OR hypertension OR pri-
mary hypertension OR essential hypertension OR sec-
ondary hypertension OR stroke OR cerebrovascular
accident OR ischemic stroke OR hemorrhagic stroke OR
vascular dementia OR transient ischemic attack OR
metabolic syndrome OR dyslipidemia OR hyperlipidemia
OR combined hyperlipidemia OR hyperlipoproteinemia
OR hyperchylomicronemia OR hypertriglyceridemia OR
hypercholesterolemia OR familial hypercholesterolemia
OR lipoprotein (a) OR type 1 diabetes mellitus OR type 2
diabetes mellitus OR hyperglycemia OR high blood glu-
cose OR glucose impairment OR secondary diabetes OR
gestational diabetes OR fasting blood glucose OR
hypoglycemia OR hyperinsulinemia OR HBA1c OR dia-
betic complications OR diabetic nephropathy OR diabetic
retinopathy OR diabetic ketoacidosis OR diabetic septic
foot OR diabetic neuropathy OR non ketotic diabetic
coma OR chronic obstructive pulmonary disease OR
chronic bronchitis OR bronchiectasis OR emphysema OR
asthma OR lung fibrosis OR pulmonary fibrosis OR lung
hyperinflation OR dyspnea OR bronchodilators OR
pulmonary function OR cancer OR neoplasm OR malig-
nancy OR tumor OR radiotherapy OR chemotherapy OR
biopsy OR tumor markers.
A total of 3776 NCD-related unique articles were
identified, of which 555 articles scored positive if they
included a genetic component (Fig. 1). A detailed search
strategy is available upon request from the authors.
Charting the data
A review was conducted on the chosen genetic articles
assessing the compatibility and comprehensiveness of the
publications included. Data extraction from each of the
full-text articles was performed using a detailed data ex-
traction form developed by the researchers. In order to
refine the final categories, the form was first piloted on 20
publications before adopting it. The final categories
included countries mentioned in the article, impact factor
(IF) of the journal, year of publication of article, NCD dis-
eases, NCD subtypes, study population, research design,
clinical focus and genetic methodologies. The journals’ IF
was reported as per Scimago [21]. Study design was
described as review, clinical or experimental. Clinical stud-
ies were described as either having a descriptive focus
(case report, case series, prevalence studies) or an etio-
logical focus (treatment and causation). The theme of the
articles was labelled according to whether the study
focused on diagnosis or prevention, control or manage-
ment, and complications or policy/health system or preva-
lence. Genetic methodologies included in the article were
also reported (proteomics, sequencing, gene expression,
pharmacogenomics, cell function, molecular genetics, bio-
informatics, epigenetics and GWAS).
Analysis
We first calculated genetic NCD publications per million
population to eliminate the effect of more populous coun-
tries. The quality (IF) of the publications was assessed by
country and differences in IFs between countries were
analysed. A time trend of total genetic NCD publications
Fig. 1 Literature search flow
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was evaluated as a percentage of publications published
per year. A detailed time trend per country covering
2011–2013 publications was also presented. To assess
research gaps, a comparison between the percent disease
heritability and percent disease literature coverage was
first conducted. Additionally, differences between the top
three disease literature coverage of the diseases and top
three causes of years of life lost per country were evalu-
ated for each country. Research deficit is highlighted when
there was a mismatch between knowledge production and
genetic NCD disease burdens.
Descriptive analysis was performed using SPSS version
20.1. χ2 test and ANOVA post hoc Tukey test were
employed for statistical analysis when appropriate. P < 0.05
was considered statistically significant.
Results and Discussion
Status of genetic NCD publications
The genetic NCD publications represented 15 % of the
total NCD publications. Comparative analysis of the 555
publications on the genetics of NCD indicated that it
was mostly high- and high-middle-income countries
(Kuwait, Lebanon and Bahrain, with the exception of
Iraq) which have the highest rate of genetic NCD
research per million capita, followed by low-middle- and
low-income countries (Morocco, Palestine and Sudan)
(Fig. 2a). This finding could be related to the relatively
high cost of conducting genetic research, the difficulty of
obtaining funds and the stakeholders’ awareness of the
value of genetic research. It was noted that, although
Kuwait had the highest number of publications per
capita, Lebanon published in higher IF journals exceed-
ing those of other countries (Fig. 2b). Notwithstanding
the limitations of IF, this may indicate that the know-
ledge produced on genetic NCD in Lebanon is likely to
create a higher impact on the community. High impact
research is also capable of generating better funding and
has the ability to provide a more perceived and trustful
information for evidence-based policy changes [22, 23].
Overall, only 0.4 % of publications were published in
very high impact journals (IF above 18), 1.1 % of papers
were published in journals with an IF of 18–10, and
approximately 6.6 % of the papers were published in
journals with an IF of 5–10. The bulk publications (over
73.8 %) appeared in journals with an IF of 1–5 and 18.1 %
in journals with an IF below 1.
The top five journals the research was published in in-
cluded Anticancer Research, PloS One, Medical Principles
and Practice, Leukemia Research, and Genetic Testing and
Molecular Biomarkers, hosting around 8.7 % of the total
number of publications. Collaboration between multiple
Arab countries was noted in only 7.4 % of genetic NCD
publications, highlighting the need for more collaborative
research among Arab researchers for a better understand-
ing of the etiology of genetic disease in the region. The
majority of publications were studies initiated by investi-
gators in the Arab countries and they were carried out at
their respective institutions. Although it is interesting to
note that 31.7 % of genetic NCD publications were
published with western collaborations in western institu-
tions. Pointing out an interest from western communities
in genetic diseases in the Arab world. The IF of those
publications was not significantly higher than the studies
published in the Arab world.
Time trends in publications of genetic NCD studies
Research activity for genetic NCD studies remained low
and fluctuating throughout the years until 2010, with a
noticeable increase until 2012, and then a drop between
2012 and 2013 (Fig. 3a). When examining the trend in
publications per country, we detected that the drop in
publications from 2012 until 2013 was mostly attributed
to decreased publications in Bahrain, Iraq, Kuwait,
Lebanon and Palestine (Fig. 3b). The listed countries
have been mostly affected by the recent wars and polit-
ical and economic turmoil happening in the Arab region.
Alternatively, the drop may be attributed to a shift in
Fig. 2 Rates of genetic NCD research and impact factor in selected Arab countries. a Studies published per million capita. b Mean impact factor.
*P < 0.05 was considered as statistically significant when compared to the country with the highest mean impact factor (Lebanon)
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research funds away from sophisticated costly research,
the impact of which will be felt on the long run [24–26].
Research design and research focus
Clinically focused research constituted the most common
type of publications produced across all the countries
(64.9 %) (Fig. 4a). This was followed by experimental
studies (21.6 %) and reviews (13.5 %). Experimental
studies were published in higher impact journals com-
pared to those with a clinical focus or reviews (mean IF
3.540, 2.120 and 2.303, respectively; P < 0.05) (Fig. 4b).
Among clinical studies, the majority of the published work
was descriptive in nature (74.9 %) with a limited focus on
etiology (25.1 %) (Fig. 4c). Genetic research methods used
in NCD publications focused mainly on sequencing and
proteomics with very limited GWAS, epigenetics and
cytogenetic studies (Fig. 4d). Although gene-specific se-
quencing was found to be abundant in the identified
papers, the lack of genome-wide sequences for association
studies and planned assessment of single nucleotide poly-
morphisms hinders the ability to develop country-specific
programs for genetic risk assessment, information gener-
ation and the ability to provide relevant counselling
support at the clinical and community level. Furthermore,
Fig. 3 Trends in genetic NCD research publications by time and country. a Trend in percent of genetic NCD research published per year from
2010 until 2013. b Trends of genetic NCD research publication from 2011 until 2013 by country
Fig. 4 Study type and methods used in genetic NCD research in selected Arab countries. a Study designs in total and per country. b Mean impact
factor by study designs. c Descriptive and etiologically focused clinical studies. d Genetic methodologies. *P < 0.05 as statistically significant
Jamaluddine et al. Health Research Policy and Systems  (2016) 14:81 Page 5 of 8
descriptive studies were more likely to use sequencing
than etiological studies (P <0.01), while etiologically fo-
cused studies have a higher proteomics analysis than
descriptive studies (P <0.01). Additionally, bioinformatics
research was found to be lacking among the identified
publications. This deters the ability to include accurate
reporting and recording of genetic disorders and genetic
profile among medical record systems. The lack of bio-
informatics research also highlights the lack of approaches
to properly deliver information on genetics and genetic
risk factors of NCD to healthcare providers, patients and
the community. Limited bioinformatics research may also
be related to the lack of expertise in the above discipline
and would benefit from directed programs for capacity
building in the region.
Comparison between percent disease heritability and
percentage of publication on specific disease types pro-
vided an opportunity to examine the gap between the re-
search focus and the disease priorities (Fig. 4). We
identified a surplus of genetic NCD research (62 %) focus-
ing on cancer and that was on account of other highly her-
itable diseases such as CVD (12.3 %) diabetes (10.9 %),
obesity (3.70 %), hypertension (2.80 %), chronic lung dys-
function (1.60 %), metabolic syndrome (0.40 %) and other
NCD diseases (6.3 %, renal dysfunction, end stage renal
disease, asthma, etc.) (Fig. 5) [27–29]. When examining
country-specific publications, the amount of research pro-
duction and the research focus did not align with country-
specific breakdown of NCD burden. If we have a look at
the top three researched NCD subtopics in each country
and the top three NCD causes of years of life lost in thou-
sands based on the global burden of diseases reports, we
notice that the genetic component of most public health
priorities topics were under-investigated, including mainly
cardiovascular diseases and congenital anomalies, followed
by diabetes, all of which are highly heritable disorders [30].
Finally, we denoted a limited focus on community and
public health oriented genetic studies. Only 1 % of total
genetic NCD studies contributed to the theme of public
health policy and community health. WHO research
priority clearly stated the importance of developing com-
munity genetics services based on genetic approaches in
healthcare, yet, our data show limited focus on preven-
tion and population-based genetic studies [2].
Conclusion
Production of genetic knowledge and informed interven-
tions has shown to reduce the prevalence and severity of
NCD [2]. One example of such successful interventions
is the ability to reduce risk of cancer by genetic assess-
ment in cases of family cancer syndrome. Genetic testing
has proven to play an important critical lifesaving role
for family members, such as in the case of colon cancer,
for example [31, 32]. Even in countries with very limited
resources, simple approaches using genetic knowledge
have been successful in single gene disorders and
present a potential for success for NCD genetic-based
interventions [33, 34]. To adapt global strategies and
align our research agendas with evidence-based needs, it
is important to generate country- and region-specific
information that render the approaches valued in health-
care and effective at the community level.
Findings from the present analysis highlighted several
areas of concern. The downward trend in the rate of
genetics publications on NCD in countries is worth not-
ing and requires close monitoring over the coming years.
The quality of research reporting needs to be improved,
judging from the low IF among publications, even in
countries with better financial resources. The study also
showed that research in the selected countries for the
past years has not been aligned with globally identified
research priorities in genetics to aid in the prevention
Fig. 5 Comparison between percent genetic NCD publications and range percentages of disease heritability
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and control of NCDs. Country-specific carrier and risk
screening is not among the top researched. Thus, identi-
fying country-specific genetic causes and assessment of
the magnitude of the burden these genetic risk factors
impose on health and the economy will not be possible.
The above findings need to be considered in light of
the study limitations. The study is based on selected
countries in the region and the search strategy that may
have missed reports published in books, articles in the
native Arabic language and articles not indexed in
PubMed. In spite of this, the study analysis is significant
and contributes to the current debate on research value
and research waste [35]. Research has to be redirected
towards NCD with the highest morbidity, heritability
and health burden within each country. Countries listed
should develop a research agenda with directed methods
to identify the burden of known genetic influenced
NCD. Bioinformatics systems should be in place to col-
lect proper genetic information and save genetic and
family history. Countries need to develop a plan to intro-
duce community genetics services that are evidence
based, highlighting the urgency for research on the topic
and proper needs assessment. A focused research plan
to include community genetics is required for its proper
integration in the Arab community. Producing the
proper genetic knowledge would lead to the adaptation
of relevant intervention programs, develop techniques to
properly implement and evaluate these interventions,
and assess their ability to produce favourable outcomes.
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